MedPath

Comparison of L-Thyroxine plus Liothyronine with L-thyroxine alone in post-surgical hypothyroidism

Not Applicable
Recruiting
Conditions
Endocrine, nutritional and metabolic disease
Registration Number
KCT0002600
Lead Sponsor
Asan Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
200
Inclusion Criteria

s/p Total thyroidectomy d/t thyroid cancer
Postoperative period 2yr-10yr
no evidence of residual disease : non-stimulated Tg <0.2 ng/mL, US (-)
Normalized thyroid function (TSH 0.1-5.0 mIU/L) with daily T4 dose ranging from 85.7mcg -150mcg
: stable thyroid function in repeated thyroid function test over 6 months interval
one of subjective persistent symptoms below compared to preoperative period [1]
•fatigue or lethargic (0-4)
•body weight gain (0-4)
•generalized body pain or ache (0-4)
•clumsiness (0-4)
?(These symptoms should be persistent at least 6 months recently.
?Patients with scores = 2 for one of each symptom considered to have subjective symptoms.)

Exclusion Criteria

Person who can not fill in the questionnaire by oneself
Pregnancy
Uncontrolled heart/liver/kidney disease, anemia (Hb <11)
Psychiatric ds/mood disorder
Other cancers, DM on insulin injection, dyslipidemia on statin
Previous history of combination therapy, within 1 year
Underlying autoimmune thyroid ds (TPO+ or lymphocytic thyroiditis in pathology)

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in the scores of quality of life questionnaires from the 1st visit to the last visit : Multidimensional fatige inventory, short form 36-item health survey
Secondary Outcome Measures
NameTimeMethod
Changes in self-reported symptoms (5-point scale), Patient preference, Changes in biochemical parameters, Assessment of changing trend of scores from quality of life by questionnaires
© Copyright 2025. All Rights Reserved by MedPath